Product Specifications
| Product (EN) | Saikokaryukotsuboreito |
| Japanese name | ツムラ柴胡加竜骨牡蛎湯エキス顆粒 |
| Manufacturer | Tsumura & Co. (株式会社ツムラ) |
| Form | Kampo dried extract granules (エキス顆粒) |
| Regulatory category | Japanese Kampo preparation — institutional display & inquiry |
| Therapeutic area (catalogue) | 精神神经 |
| Pack size | Per official packaging — confirmed on quotation |
| Country of origin | Japan |
| Storage | Per the official Japanese package insert |
About this product
Saikokaryukotsuboreito (ツムラ柴胡加竜骨牡蛎湯エキス顆粒) is a Japanese Kampo preparation supplied as Kampo dried extract granules (エキス顆粒) by Tsumura & Co. (株式会社ツムラ), catalogued here under the 精神神经 grouping. As a Japanese Kampo product it is manufactured under Japan’s Good Manufacturing Practice (GMP) requirements, giving consistent, traceable, batch-controlled quality — the qualities international buyers value in Japanese-made Kampo. Tsubaki Trading supplies this product to overseas pharmacies, clinics and distributors on a business-to-business basis. Learn more in our guide to Japanese herbal medicine.
Composition
The crude-drug (生薬) composition of this formula and exact quantities are stated in the official Japanese package insert (添付文書) and provided on inquiry.
Approved indications & usage (Japan)
The following reproduces the officially approved Japanese indications (効能・効果) and dosage (用法・用量) from the manufacturer’s package insert (添付文書), provided for professional institutional reference only. It reflects Japanese regulatory approval — objective regulatory information, not a therapeutic claim, recommendation, or approval for any other market, and not consumer advertising. Products are supplied for lawful import and registration by qualified buyers.
| 効能・効果 (Approved indications, Japan) | 比較的体力があり、心悸亢進、不眠、いらだち等の精神症状のあるものの次の諸症：高血圧症、動脈硬化症、慢性腎臓病、神経衰弱症、神経性心悸亢進症、てんかん、ヒステリー、小児夜啼症、陰萎 |
|---|---|
| Indications — reference translation | For relatively robust constitutions with palpitations, insomnia, irritability and similar psychological symptoms: hypertension, arteriosclerosis, chronic kidney disease, neurasthenia, nervous palpitations, epilepsy, hysteria, night-crying in children, impotence. |
| 用法・用量 (Dosage & administration) | 通常、成人1日7.5gを2〜3回に分割し、食前又は食間に経口投与する。年齢・体重・症状により適宜増減する。 Adults: 7.5 g/day in 2–3 divided doses, before or between meals; adjust by age, body weight and symptoms. |
| Precautions | Consult the official package insert for contraindications, precautions and interactions; supplied for professional use. |
| Official source | Kusuri-no-Shiori (RAD-AR patient information) |
Compliance & handling
Japanese Kampo preparation — displayed for institutional reference only. Not sold online. Import, distribution and use are subject to the regulations of the destination country or region, which the buyer is responsible for confirming.
Information on this page is provided for institutional reference and reproduces objective product information as labelled by the manufacturer. It does not constitute any claim of efficacy, dosage guidance or medical advice.
Sourcing & export
- Authenticity: sourced directly through regular domestic Japanese channels.
- MOQ & lead time: by quotation — tell us your quantity and destination.
- Logistics: EMS / DHL / FedEx worldwide.
- Response: inquiries answered within 24 business hours.
- Documents on request: composition sheet / CoA, GMP certificate, CPP, official Japanese package insert.
Submit an inquiry for a quotation »
Frequently asked questions
Is the packaging original Japanese?
Yes — products are supplied in original Japanese-market packaging.
What export documents can you provide?
On request: composition sheet / CoA, GMP certificate, Certificate of Pharmaceutical Product (CPP) and the official Japanese package insert.
What is the minimum order quantity?
MOQ and lead time are confirmed on your quotation. Send your target quantity and destination through the inquiry form.
Which countries do you ship to?
We export worldwide via EMS / DHL / FedEx; the destination country’s import rules apply.
Reviews
There are no reviews yet.